What does increased signaling on a Magnetic Resonance Imaging (MRI) scan indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Increased Signal on MRI: Clinical Interpretation

Increased signal intensity on MRI represents tissue with higher water content, appearing bright on T2-weighted, FLAIR, or STIR sequences, and indicates edema, inflammation, demyelination, ischemia, or other pathological processes depending on the anatomic location and clinical context. 1

Fundamental MRI Signal Characteristics

The appearance of "increased signal" depends critically on the specific MRI sequence used:

  • T2-weighted and FLAIR sequences: Increased signal (hyperintensity) reflects elevated tissue water content from edema, inflammation, gliosis, demyelination, or ischemic injury 2, 1
  • STIR sequences: Highly sensitive for detecting increased water content in tissues, representing bone marrow edema, inflammatory changes, or stress reactions in musculoskeletal imaging 3
  • Diffusion-weighted imaging (DWI): Restricted diffusion (bright signal) indicates cytotoxic edema from acute cellular injury, most commonly seen in acute stroke 2

Anatomic Location-Specific Interpretation

Brain Parenchyma

White matter hyperintensities on T2/FLAIR sequences have distinct etiologies based on patient age and distribution:

  • Age >50 years with vascular risk factors: Most commonly represents cerebral small vessel disease (chronic microvascular ischemic changes), appearing as small (<6 mm), non-enhancing lesions in deep white matter and periventricular regions 1
  • Periventricular distribution: Chronic microvascular ischemia causes myelin loss, axonal damage, gliosis, and perivascular space dilation, significantly increasing risk of cognitive impairment, stroke, and mortality 1
  • Multiple sclerosis: Requires typical lesions in at least two characteristic regions (periventricular, juxtacortical, infratentorial, or spinal cord), with ovoid lesions ≥3 mm perpendicular to corpus callosum ("Dawson's fingers") 2, 1

Critical red flags that suggest alternative diagnoses include:

  • Enhancement persisting >3 months (consider sarcoidosis or vascular malformation) 2
  • Leptomeningeal enhancement (neurosarcoidosis, granulomatous disease, or in progressive MS on post-contrast FLAIR) 2
  • Punctate/miliary enhancement (CLIPPERS, vasculitis, PML, Susac syndrome) 2
  • Purely cortical enhancement (subacute ischemia) 2

Spinal Cord

Increased T2 signal intensity in the spinal cord indicates intramedullary pathology from compression, inflammation, ischemia, demyelination, or trauma 4:

  • Cervical spondylotic myelopathy: T2 hyperintensity appears in 65-80% of patients with moderate-to-severe disease, representing edema, gliosis, myelomalacia, or ischemic injury 4
  • Prognostic significance: Combined T1 hypointensity with T2 hyperintensity indicates irreversible myelomalacia and predicts poor surgical outcomes 4
  • Multiple sclerosis: Focal lesions occupying <50% of cord cross-section, extending <2 vertebral segments 4
  • Neuromyelitis optica: Longitudinally extensive lesions with central cord predilection 4

Red flags in spinal cord imaging include:

  • Swelling with long segments (neuromyelitis optica spectrum disorders, anti-MOG-IgG disease) 2
  • Preferential involvement of caudal spine (anti-MOG-IgG disease) 2
  • "Snake eye" or "owl's eye" sign of bilateral anterior grey matter horn hyperintensities (ischemia/infarction) 2

Musculoskeletal Tissues

Increased signal on STIR sequences in bone and soft tissue represents 3:

  • Bone marrow edema: Indicates inflammation, stress reactions, or traumatic injury (sensitivity 79-82%, specificity 89-97%) 3
  • Fascial fluid/edema: Particularly important for detecting necrotizing fasciitis (93% sensitivity) 3
  • Sacroiliac joints: Active inflammation in axial spondyloarthropathy, though bone marrow edema can be nonspecific in up to 30% of healthy controls 3

Critical principle: STIR should never be used in isolation—always combine with T1-weighted sequences to differentiate acute inflammatory changes from chronic structural changes 3

Special Context: Amyloid-Modifying Therapy (ARIA-E)

In patients receiving anti-amyloid immunotherapy, increased signal on FLAIR sequences represents Amyloid-Related Imaging Abnormalities with Edema (ARIA-E) 2:

  • Manifests as increased signal in parenchyma and/or leptomeninges, most commonly in parietal, occipital, and frontal lobes 2
  • Represents vasogenic edema (increased extracellular fluid from capillary endothelial permeability) rather than cytotoxic edema 2
  • Usually transient, not associated with restricted diffusion or tissue necrosis 2
  • Leptomeningeal involvement may represent proteinaceous fluid effusion rather than subarachnoid hemorrhage 2

Temporal Evolution and Clinical Significance

Acute vs. chronic changes require different interpretation:

  • Acute hemorrhage: High density on CT within 1 week, or extracellular methemoglobin (high signal on T1/T2) on MRI within 2 weeks 2
  • Vasogenic edema: Transient, reversible, without restricted diffusion 2
  • Cytotoxic edema: Restricted diffusion on DWI from acute cellular damage (e.g., stroke) 2
  • Chronic changes: Gliosis, myelomalacia, or fibrosis developing over time 4, 5

Practical Clinical Algorithm

For brain white matter hyperintensities:

  1. Patient >50 years with vascular risk factors: Attribute to cerebral small vessel disease; aggressively optimize vascular risk factors (blood pressure, statins, diabetes management, smoking cessation) 1
  2. Patient <50 years without vascular risk factors: Consider follow-up MRI in 3-6 months; if new lesions appear in characteristic MS locations, pursue MS evaluation with lumbar puncture and evoked potentials 1
  3. Any age with atypical features (enhancement >3 months, leptomeningeal involvement, mass effect): Pursue alternative diagnoses 2

For spinal cord T2 hyperintensity:

  1. Acute onset: Consider ischemia, trauma, or acute inflammatory process 4
  2. Subacute/chronic with compression: Assess for surgical candidacy; absence of T2 signal predicts best recovery, while T1 hypointensity + T2 hyperintensity predicts poor outcomes 4
  3. No compression with longitudinally extensive lesion: Evaluate for neuromyelitis optica, ADEM 4
  4. Focal lesion <2 segments: Consider MS, obtain contrast-enhanced images 4

For musculoskeletal STIR hyperintensities:

  1. Always obtain T1-weighted images to differentiate acute from chronic changes 3
  2. Bone marrow edema in sacroiliac joints: Deep lesions extending ≥1 cm from articular surface are more specific for pathologic inflammation 3
  3. Fascial edema with clinical concern for infection: STIR has 93% sensitivity for necrotizing fasciitis; fascial thickening ≥3 mm has 86% sensitivity 3

Common Pitfalls to Avoid

  • Do not diagnose MS from a single small white matter lesion: Lesions <3 mm do not meet McDonald criteria, and MS requires lesions in ≥2 characteristic regions 1
  • Do not assume all periventricular hyperintensities are pathologic: Symmetric linear hyperintensities abutting lateral ventricles ("periventricular capping") and lesions <3 mm are normal variants 1
  • Do not interpret STIR hyperintensities without T1-weighted images: Up to 30% of healthy controls show bone marrow edema in sacroiliac joints 3
  • Do not assume enhancement always indicates active disease: Vascular structures and developmental venous anomalies can mimic pathologic enhancement 2

References

Guideline

Cerebral Small Vessel Disease Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Speckled STIR Hyperintensities on MRI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Spinal Cord Injury and Disease Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.